Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin Duration in Adjuvant Colon Cancer
NCT01092481Phase 3Unknown
- Sponsor
- Samsung Medical Center
- Start
- Jan 2010
- Primary completion
- Dec 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in colon cancer, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT01092481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092481.